At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 283 enrolled
Drug / intervention
Tranexamic Acid Injectable Solution +1 moredrug
Likely dose
Tranexamic Acid Injectable Solution 1gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Tranexamic Acid Prior to Surgery in the Geriatric Hip Fracture Population for the Reduction of Post-Operative Blood Transfusion
In Brief
A Phase 3 clinical trial evaluating Tranexamic Acid Injectable Solution and Placebo for Hip Fractures. Completed, enrolled 283 participants across 1 site.
Detailed Summary
The overall design of the study is a prospective, double-blinded, randomized study in the geriatric hip fracture population comparing those who receive intravenous tranexamic acid prior to incision to those who receive a placebo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHip Fractures
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2020202120222023202420252026
First PostedApr 2019
Enrollment StartFeb 2020
Primary CompletionDec 2022
TodayJul 2026
First PostedApr 23, 2019
Enrollment StartFeb 1, 2020
Primary CompletionDec 9, 2022
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 7.2 years ago
Interventions
Tranexamic Acid Injectable Solutiondrug
100 cc normal saline mixed with 1g of tranexamic acid in solution
Placeboother
100 cc normal saline